Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
1.200
+0.040 (3.45%)
At close: Mar 17, 2026, 4:00 PM EDT
1.250
+0.050 (4.17%)
After-hours: Mar 17, 2026, 7:57 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $156.56 million as of March 17, 2026. Its market cap has increased by 46.05% in one year.
Market Cap
156.56M
Enterprise Value
141.65M
1-Year Change
46.05%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $156.56M, a decrease of -35.73%. That is a compound annual growth rate of -6.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 151.34M | 135.75% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nkarta | 164.79M |
| Heron Therapeutics | 163.33M |
| Vaxart | 162.43M |
| Molecular Partners AG | 159.75M |
| Evaxion | 159.72M |
| Kalaris Therapeutics | 159.34M |
| Artiva Biotherapeutics | 156.21M |
| Karyopharm Therapeutics | 153.72M |